Microdosing LSD for Alzheimer’s proves safe in early human trial
Results have been published from one of the first placebo-controlled clinical trials investigating the effects of microdosing LSD. This Phase 1 trial is exploring whether microdosing could be useful as a therapeutic tool to treat Alzheimer’s disease. Continue reading Microdosing LSD for Alzheimer’s proves safe in early human trial